Completed NA INTERVENTIONAL 2-arm NCT00709280

Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS)

Sponsor: CF Therapeutics Development Network Coordinating Center

Interventions 0.9% Isotonic Saline (IS) 7% Hypertonic Saline (HS)

Updated 7 times since 2017 Last updated: Feb 11, 2013 Started: Apr 30, 2009 Primary completion: Oct 31, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00709280, this NA trial focuses on Cystic Fibrosis and remains completed. Sponsored by CF Therapeutics Development Network Coordinating Center, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CF Therapeutics Development Network Coordinating Center
Cystic Fibrosis Foundation
National Heart, Lung, and Blood Institute (NHLBI)

Data source: CF Therapeutics Development Network Coordinating Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Aurora, United States , Baltimore, United States , Birmingham, United States , Buffalo, United States , Chapel Hill, United States , Charlottesville, United States , Chicago, United States , Cincinnati, United States , Columbus, United States and 19 more locations